Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Congreso ISTH 2017: Últimas investigaciones en trombosis, hemostasia y biología vascular


      News provided by

      International Society on Thrombosis and Haemostasis

      Jul 03, 2017, 04:48 ET

      Share this article

      Share this article


      BERLÍN, July 3, 2017 /PRNewswire/ --

      - Congreso ISTH 2017: Expertos internacionales se reúnen en Berlín para mostrar las últimas investigaciones en trombosis, hemostasia y biología vascular

      Bajo el tema "Transcendiendo los límites científicos", el Congreso 2017 de la Sociedad Internacional de Trombosis y Hemostasia (ISTH, por sus siglas en inglés). Este evento mundial, que se celebrará entre el 8 y el 13 de julio, busca mejorar el tratamiento de pacientes que sufren desórdenes de sangrado y coagulación, como la hemofilia o la trombosis. Los principales expertos en la materia presentarán la última investigación básica, translacional y clínica, destacando los avances en diagnósticos y terapias.

      "Fiel a la emoción en torno a uno de los eventos científicos líderes en el campo de la trombosis, la hemostasia y la biología vascular, el Congreso ISTH 2017 presentará un rango de revolucionarias ofertas de investigación e innovación diseñadas para impulsar el intercambio mutuo y debate científico en torno a temas altamente esperados", afirma Johannes Oldenburg, profesor y doctor en medicina de la University Clinic Bonn en Alemania y presidente del Congreso ISTH 2017. "El encuentro mostrará lo último en descubrimientos científicos, así como opciones de diagnóstico y tratamiento para cubrir mejor las necesidades de los pacientes", asegura.

      Las cifras de asistencia alcanzan un máximo histórico 

      Con más de 9.000 participantes de aproximadamente 90 países, el congreso de este año supera todos los récords de asistencia del ISTH, convirtiéndose en el mayor encuentro dedicado a la trombosis y la hemostasia hasta la fecha. Esto se corresponde con la segunda mayor tasa de presentación del congreso hasta ahora: 3.120 abstracts científicos presentados por médicos, científicos, académicos y estudiantes de 83 países. Con un amplio abanico de temas, los participantes se reunirán para exponer sus presentaciones científicas, incluyendo estudios no publicados; intercambiar los últimos hallazgos científicos y su aplicación clínica, así como participar en sesiones de posters interactivas y comunicación oral, y simposios de abstracts.

      Oportunidad para previsualizar las últimas novedades científicas 

      La sesión informativa del ISTH 2017 oficial tendrá lugar el lunes, 10 de julio, de 11:30 am a 12:30 pm, en la que se ofrecerá una visión general de la última evidencia científica clave y los hallazgos presentados en el congreso. Moderada por el profesor y doctor en medicina Wolfram Ruf, de la Johannes Gutenberg University Mainz en Alemania, la sesión informativa cubrirá temas clave como el tratamiento de la hemofilia, la gestión de los pacientes con tromboembolismo venoso y la inversión de los mecanismos de anticoagulación. Las presentaciones sobre de las últimas novedades científicas, incluidas en la sesión informativa de ISTH 2017, tendrán lugar durante el congreso en los siguientes días:

      Lunes, 10 de julio   

      • Efficacy, Safety and Pharmacokinetics (PK) of Emicizumab (ACE910) Prophylaxis (Px) in Persons with Hemophilia A with Inhibitors (PwHAwI): Randomized, Multicenter, Open-label, Phase 3 Study (HAVEN 1) por el profesor y doctor en medicina Johannes Oldenburg, presidente del Congreso ISTH 2017, Institute of Experimental Hematology and Transfusion Medicine, University Clinic Bonn, Alemania - Abstract Symposia Session, 15:15, Hall B
      • Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: Interim Results from a Phase 2 Extension Study in Patients with Hemophilia A or B with and Without Inhibitors por el profesor y doctor en medicina John Pasi, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Reino Unido - Abstract Symposia Session, 15:30, Hall B

      Martes, 11 de julio  

      • Interim Results from a Phase 1/2 AAV5-FVIII Gene Transfer in Patients with Severe Hemophilia A por el profesor y doctor en medicina John Pasi, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Reino Unido - Oral Communication Session, 9:30, Hall B
      • Final Results of RE-VERSE AD Study: Reversal of Dabigatran by its Specific Reversal Agent Idarucizumab in Patients with Uncontrolled Bleeding or Requiring Urgent Surgery/Procedures por el profesor y doctor en medicina Charles Pollack, Thomas Jefferson University, Philadelphia, Estados Unidos - Oral Communication Session, 10:24, Hall B

      Miércoles, 12 de julio   

      • Clinical Characteristics and Management of 10,329 Patients with a Confirmed Diagnosis of Venous Thromboembolism: The GARFIELD-VTE Registry por el profesor y doctor en medicina Walter Ageno, Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italia - Abstract Symposia Session, 16:00, Room New York

      Para más información sobre el Congreso ISTH 2017, puede visitar el siguiente enlace: http://www.isth2017.org.

      Acerca de la ISTH   

      Fundada en 1969, la ISTH es la organización sin ánimo de lucro líder mundial dedicada a avanzar el conocimiento, la prevención, el  diagnóstico y el tratamiento de desórdenes trombóticos y de sangrado. La ISTH es una organización de afiliados profesional e internacional con más de 4.500 médicos, investigadores y educadores que trabajan para mejorar las vidas de los pacientes en más de 94 países de todo el mundo. Entre sus actividades e iniciativas están los programas de educación y estandarización, actividades de investigación, encuentros y congresos, publicaciones revisadas por homólogos, comités de expertos y el Día Mundial de la Trombosis, que se celebra el 13 de octubre de cada año. En este enlace puede consultar más información sobre la organización: http://www.isth.org.

      Información de interés 

      • Registro complementario para prensa: http://www.isth2017.org/press-registration.html
      • Sea un participante digital a través de ISTH Congress Live Stream: http://www.isth2017.org/live-broadcast.html  
      • Research and Practice in Thrombosis and Hemostasis es una nueva publicación electrónica de acceso abierto de la ISTH. Revise los abstracts de la ISTH 2017 aquí: http://onlinelibrary.wiley.com/doi/10.1111/rth2.2017.1.issue-S1/issuetoc

      Para más información:
      El equipo de prensa de Weber Shandwick en nombre de ISTH
      +49-30-20-35-1-266
      [email protected]  

      Barbara Krolak
      Especialista en Relación y Campaña
      International Society on Thrombosis and Hemostasis
      +1-919-929-3807
      [email protected]

      Modal title

      Also from this source

      World Thrombosis Day campaign urges global action to protect women against blood clots

      World Thrombosis Day campaign urges global action to protect women against blood clots

      One in four people worldwide die from conditions caused by thrombosis, yet blood clots remain among the most overlooked and misunderstood serious...

      ISTH selects Vancouver to host its 2027 Congress

      ISTH selects Vancouver to host its 2027 Congress

      The International Society on Thrombosis and Haemostasis (ISTH) announces that its 2027 Congress will be held in the city of Vancouver, Canada, from...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Publishing & Information Services

      Publishing & Information Services

      Trade Show News

      Trade Show News

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.